XERS vs IPGP
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
XERS · Xeris Pharmaceuticals$15.20 ▲ 16.21%
IPGP · IPG Photonics$65.31 ▲ 5.29%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- XERS +96.9%
- IPGP -24.6%
Head to head
| Metric | XERS | IPGP |
|---|---|---|
| Price | $15.20 | $65.31 |
| Change today | ▲ 16.21% | ▲ 5.29% |
| Market cap | $2.78B | $2.78B |
| Return, 3 months | +90.2% | -23.1% |
| Return, year to date | +93.6% | -8.8% |
| Return, 1 year | +104.6% | -25.7% |
| P/E (TTM) | – | 69.5 |
| P/B | 56.9 | 1.3 |
| P/E percentile vs own 5y | 0th | 81st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +28.7% | +11.1% |
| Net profit growth (YoY) | -1,513.1% | -20.6% |
| Gross margin | 86.6% | 38.4% |
| Operating margin | 10.9% | 4.0% |
| Net margin | -5.1% | 2.6% |
| Return on equity | – | 1.3% |
| Analyst target vs. price | -21.1% | +104.4% |
| Analyst buy share | 80% | 100% |
| RSI (14) | 82 | 36 |
| 30-day volatility | 94.6% | 58.9% |
| Max drawdown, 1 year | -46.6% | -59.7% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- XERS is the largest of the group by market value.
- XERS has returned the most over the past year.
- XERS is growing revenue fastest.
- IPGP keeps the most profit per dollar of sales.
- IPGP has been the calmest stock over the last 30 days.